The EMA has approved increased manufacturing capacity for the Pfizer Covid-19 vaccine.
The European Medicines Agency’s given the green light for the move at a factory in Belgium.
The agency says it is expected to have a significant and immediate impact on the supply of the vaccine in the European Union.